Flex Balance Sheet Health
Financial Health criteria checks 6/6
Flex has a total shareholder equity of $5.0B and total debt of $3.7B, which brings its debt-to-equity ratio to 74.1%. Its total assets and total liabilities are $18.6B and $13.6B respectively. Flex's EBIT is $1.1B making its interest coverage ratio 7. It has cash and short-term investments of $2.6B.
Key information
74.1%
Debt to equity ratio
US$3.71b
Debt
Interest coverage ratio | 7x |
Cash | US$2.60b |
Equity | US$5.00b |
Total liabilities | US$13.58b |
Total assets | US$18.59b |
Recent financial health updates
Does Flex (NASDAQ:FLEX) Have A Healthy Balance Sheet?
Oct 09Flex (NASDAQ:FLEX) Has A Pretty Healthy Balance Sheet
Apr 06Recent updates
Flex: Becoming A Better Business In Its Transformation
Dec 27Many Still Looking Away From Flex Ltd. (NASDAQ:FLEX)
Dec 02A Look At The Fair Value Of Flex Ltd. (NASDAQ:FLEX)
Oct 24Does Flex (NASDAQ:FLEX) Have A Healthy Balance Sheet?
Oct 09Flex Is Not Cheap Amid Geopolitical And Innovation Risks
Oct 01Is It Too Late To Consider Buying Flex Ltd. (NASDAQ:FLEX)?
Sep 13We Think Flex's (NASDAQ:FLEX) Solid Earnings Are Understated
Aug 03Shareholders May Not Be So Generous With Flex Ltd.'s (NASDAQ:FLEX) CEO Compensation And Here's Why
Aug 01Flex Ltd. (NASDAQ:FLEX) Shares Could Be 30% Below Their Intrinsic Value Estimate
Jul 11Flex Provides Exposure To 2 Verticals That Have Strong Secular Tailwinds
Jul 02Why We're Not Concerned About Flex Ltd.'s (NASDAQ:FLEX) Share Price
Jun 21Flex (NASDAQ:FLEX) Has A Pretty Healthy Balance Sheet
Apr 06Flex Ltd.: Undervalued With Solid Fundamentals
Apr 04Flex: Growth Potential After The Nextracker Spin-Off
Jan 20Financial Position Analysis
Short Term Liabilities: FLEX's short term assets ($13.4B) exceed its short term liabilities ($9.3B).
Long Term Liabilities: FLEX's short term assets ($13.4B) exceed its long term liabilities ($4.3B).
Debt to Equity History and Analysis
Debt Level: FLEX's net debt to equity ratio (22.1%) is considered satisfactory.
Reducing Debt: FLEX's debt to equity ratio has reduced from 106.6% to 74.1% over the past 5 years.
Debt Coverage: FLEX's debt is well covered by operating cash flow (43.7%).
Interest Coverage: FLEX's interest payments on its debt are well covered by EBIT (7x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/30 22:59 |
End of Day Share Price | 2024/12/30 00:00 |
Earnings | 2024/09/27 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Flex Ltd. is covered by 28 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
James Kelleher | Argus Research Company |
George Wang | Barclays |
Ruplu Bhattacharya | BofA Global Research |